PSTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Poseida Therapeutics (PSTX) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

PSTX is expected to report earnings to fall 297.62% to -41 cents per share on March 06

Poseida Therapeutics PSTX Stock Earnings Reports

Q4'24

Est.

$-0.41

Q3'24

Beat

by $0.63

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.17

Q4'23

Beat

by $0.12

The last earnings report on November 07 showed earnings per share of 20 cents, beating the estimate of -41 cents. With 535.76K shares outstanding, the current market capitalization sits at 312.86M.

View a ticker or compare two or three

Compare

PSTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PSTX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for PSTX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

9390 Towne Centre Drive

Phone

+1 858 779-3100

Employees

330

Web

https://www.poseida.com